Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance

Many patients remain unresponsive to intensive PD-1/PD-L1 blockade therapy despite the presence of tumor-infiltrating lymphocytes. We propose that impaired innate sensing might limit the complete activation of tumor-specific T cells after PD-1/PD-L1 blockade. Local delivery of type I interferons (IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yong, Tang, Haidong, Guo, Jingya, Qiu, Xiangyan, Yang, Zecheng, Ren, Zhenhua, Sun, Zhichen, Bian, Yingjie, Xu, Lily, Xu, Hairong, Shen, Jiao, Han, Yanfei, Dong, Haidong, Peng, Hua, Fu, Yang-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214895/
https://www.ncbi.nlm.nih.gov/pubmed/30389912
http://dx.doi.org/10.1038/s41467-018-06890-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214895/
https://www.ncbi.nlm.nih.gov/pubmed/30389912
http://dx.doi.org/10.1038/s41467-018-06890-y

Ejemplares similares